Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Macarena Knop"'
Autor:
Wojciech Francuzik, Sabine Dölle-Bierke, Macarena Knop, Kathrin Scherer Hofmeier, Ewa Cichocka-Jarosz, Blanca E. García, Roland Lang, Ioana Maris, Jean-Marie Renaudin, Margitta Worm
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Refractory anaphylaxis (unresponsive to treatment with at least two doses of minimum 300 μg adrenaline) is a rare and often fatal hypersensitivity reaction. Comprehensive data on its definition, prevalence, and risk factors are missing. Using the da
Externí odkaz:
https://doaj.org/article/0b980a4525954b6daba00d99d78fefad
Publikováno v:
Journal of the European Academy of Dermatology and Venereology. 33:2253-2263
Adherence describes how a patient follows a medical regime recommended by a healthcare provider. Poor treatment adherence represents a complex and challenging problem of international healthcare systems, as it has a substantial impact on clinical out
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da942e2b8bc0f2bdedf46a37071f30dc
https://doi.org/10.1111/jdv.15913
https://doi.org/10.1111/jdv.15913
Autor:
Margitta Worm, Nicola Wagner, Ewa Cichocka-Jarosz, Sabine Müller, Ioana Maris, Thomas Spindler, Anne Moeser, Montserrat Fernandez-Rivas, Sabine Dölle-Bierke, Alice Koehli, Jonathan O'b Hourihane, Uta Rabe, Claudia Pföhler, Macarena Knop, Maria Beatrice Bilò, Regina Treudler, Tihomir B. Mustakov, Vera Mahler, Luis Felipe Ensina, Victoria Cardona, J.-M. Renaudin, Iwona Poziomkowska-Gęsicka, Lars Lange, Kathrin Scherer Hofmeier, Bettina Wedi, Andrea Bauer, Nikolaos G. Papadopoulos, Magdalena Kraft, George Christoff, Linus Grabenhenrich, Blanca E. García, Roland Lang
BACKGROUND Patients with a history of anaphylaxis are at risk of future anaphylactic reactions. Thus, secondary prevention measures are recommended for these patients to prevent or attenuate the next reaction. METHODS Data from the Anaphylaxis Regist
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2778c2bb2bda72fc7fbfa1e7ff9078a6
https://opus4.kobv.de/opus4-fau/files/15365/ALL_ALL14069.pdf
https://opus4.kobv.de/opus4-fau/files/15365/ALL_ALL14069.pdf
Publikováno v:
Expert Review of Clinical Pharmacology. 11:467-474
Dupilumab is a new treatment option for patients with moderate-to-severe atopic dermatitis. It blocks IL-4/IL13-signaling and thereby inhibits receptor signaling downstream the JAK-STAT-pathway. Three of the main disease mechanisms of atopic dermatit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::765bd95f2fa15fef9898e74e79192d9c
https://doi.org/10.1080/17512433.2018.1449642
https://doi.org/10.1080/17512433.2018.1449642
Autor:
Wojciech Francuzik
This is the first release of this repository.
This compendium was created with the use of 'rrtools' package for R stats.
This compendium was created with the use of 'rrtools' package for R stats.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5154fc4fc180362e162738a5c9b0d12b